Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.
State Key Laboratory for Pharmaceutical Biotechnology, Department of Pharmacology and Pharmacy and University of Hong Kong, Hong Kong, China.
Vascul Pharmacol. 2018 Mar;102:11-20. doi: 10.1016/j.vph.2017.05.003. Epub 2017 May 26.
Endothelial dysfunction accompanied by an increase in oxidative stress is a key event leading to hypertension. As dietary nitrite has been reported to exert antihypertensive effect, the present study investigated whether chronic oral administration of sodium nitrite improves vascular function in conduit and resistance arteries of hypertensive animals with elevated oxidative stress.
Sodium nitrite (50mg/L) was given to angiotensin II-infused hypertensive C57BL/6J (eight to ten weeks old) mice for two weeks in the drinking water. Arterial systolic blood pressure was measured using the tail-cuff method. Vascular responsiveness of isolated aortae and renal arteries was studied in wire myographs. The level of nitrite in the plasma and the cyclic guanosine monophosphate (cGMP) content in the arterial wall were determined using commercially available kits. The production of reactive oxygen species (ROS) and the presence of proteins (nitrotyrosine, NOx-2 and NOx-4) involved in ROS generation were evaluated with dihydroethidium (DHE) fluorescence and by Western blotting, respectively.
Chronic administration of sodium nitrite for two weeks to mice with angiotensin II-induced hypertension decreased systolic arterial blood pressure, reversed endothelial dysfunction, increased plasma nitrite level as well as vascular cGMP content. In addition, sodium nitrite treatment also decreased the elevated nitrotyrosine and NOx-4 protein level in angiotensin II-infused hypertensive mice.
The present study demonstrates that chronic treatment of hypertensive mice with sodium nitrite improves impaired endothelium function in conduit and resistance vessels in addition to its antihypertensive effect, partly through inhibition of ROS production.
伴有氧化应激增加的内皮功能障碍是导致高血压的关键事件。由于膳食亚硝酸盐已被报道具有降压作用,本研究旨在探讨慢性口服亚硝酸钠是否能改善氧化应激升高的高血压动物的血管功能。
在饮用水中给予血管紧张素 II 输注的高血压 C57BL/6J(8 至 10 周龄)小鼠亚硝酸钠(50mg/L),持续两周。使用尾套法测量动脉收缩压。在钢丝肌动描记器中研究离体主动脉和肾动脉的血管反应性。使用市售试剂盒测定血浆中亚硝酸盐水平和动脉壁中环鸟苷单磷酸(cGMP)含量。用二氢乙啶(DHE)荧光法和 Western blot 法分别评估活性氧(ROS)的产生和涉及 ROS 产生的蛋白质(硝基酪氨酸、NOx-2 和 NOx-4)的存在。
给血管紧张素 II 诱导的高血压小鼠连续两周给予亚硝酸钠可降低收缩压,逆转内皮功能障碍,增加血浆亚硝酸盐水平和血管 cGMP 含量。此外,亚硝酸钠治疗还降低了血管紧张素 II 输注的高血压小鼠中升高的硝基酪氨酸和 NOx-4 蛋白水平。
本研究表明,慢性给予高血压小鼠亚硝酸钠可改善其在管腔和阻力血管中的内皮功能障碍,除了具有降压作用外,还部分通过抑制 ROS 产生。